Stock Market & Financial Investment News

News Breaks December 14, 2012 07:12 EDT CVS CVS Caremark upgraded to Outperform from Neutral at Macquarie Macquarie expects CVS Caremark's long-term growth to benefit from Healthcare reform laws and for shares to outperform based on limited 2013 negative earnings revisions, a stronger 2014 PBM selling season, and generics. Price target raised to $55 from $50. News For CVS From The Last 14 Days Check below for free stories on CVS the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 15, 2013 17:30 EDT CVS Relational Investors gives quarterly update on stakes Subscribe for More Information May 13, 2013 09:56 EDT CVS CVS Caremark has a conference call hosted by JPMorgan JPMorgan Analyst Gill will host a conference call with CEO Larry Merlo on May 16 at 11 am. 08:32 EDT CVS Walgreens extends CVS Caremark network provider agreement Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.